Abstract
We present our preliminary results. Of 30 patients with M1 renal cell carcinoma, 21 were included in our prospective controlled pilot study until March 14, 1992. These 21 patients were evaluated for efficacy in the treatment with recombinant interferon alfa-2b in combination with 5-fluorouracil (5-FU).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Goldschmidt, A.J.W., Tunn, U.W. (1994). Response According to Site of Metastases in Patients with Metastatic RCC (Renal Cell Carcinoma) During Treatment with Interferon Alpha in Combination with 5-Fluorouracil. In: Staehler, G., Pomer, S. (eds) Contemporary Research on Renal Cell Carcinoma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78609-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-78609-9_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78611-2
Online ISBN: 978-3-642-78609-9
eBook Packages: Springer Book Archive